Literature DB >> 2240271

Long-term arterial pressure control: an analysis from animal experiments and computer and graphic models.

A C Guyton1.   

Abstract

Long-term arterial pressure control is very different from acute control, because many of the acute control systems are overridden by a single long-term mechanism that has little to do with short-term control. This is the renal fluid volume mechanism for pressure control. It is based on a simple functional property of the kidney: as the arterial pressure rises, the kidney output of water and electrolytes increases dramatically. When the output rises above the net intake of water and electrolytes, negative body fluid balance occurs, causing both the body fluid volume and the pressure to decrease. This decrease continues until the kidney fluid output exactly balances the net fluid intake. Conversely, if the pressure falls below the exact level for balance, intake becomes greater than output; then fluid builds up in the body and the pressure rises until intake and output again exactly balance each other. This fluid mechanism for pressure control has been known from the beginning of blood pressure research. However, its overpowering importance was not appreciated until a mathematical computer analysis in 1966 demonstrated the renal-fluid feedback mechanism to have infinite feedback gain for long-term pressure control. This is the principal topic of the present review.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2240271     DOI: 10.1152/ajpregu.1990.259.5.R865

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  42 in total

Review 1.  Heme oxygenase, a novel target for the treatment of hypertension and obesity?

Authors:  Peter A Hosick; David E Stec
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-09       Impact factor: 3.619

Review 2.  The expanding role of aldosterone in the regulation of body Na content.

Authors:  Jurgen Schnermann
Journal:  Pflugers Arch       Date:  2003-03-21       Impact factor: 3.657

3.  Sodium-selective salt sensitivity: its occurrence in blacks.

Authors:  Olga Schmidlin; Alex Forman; Anthony Sebastian; R Curtis Morris
Journal:  Hypertension       Date:  2007-10-15       Impact factor: 10.190

4.  Combined effects of carbonic anhydrase inhibitor and adenosine A1 receptor antagonist on hemodynamic and tubular function in the kidney.

Authors:  Cynthia M Miracle; Timo Rieg; Roland C Blantz; Volker Vallon; Scott C Thomson
Journal:  Kidney Blood Press Res       Date:  2007-09-20       Impact factor: 2.687

Review 5.  A mathematical model of salt-sensitive hypertension: the neurogenic hypothesis.

Authors:  Viktoria A Averina; Hans G Othmer; Gregory D Fink; John W Osborn
Journal:  J Physiol       Date:  2014-10-27       Impact factor: 5.182

Review 6.  Chronic nitric oxide inhibition model six years on.

Authors:  R Zatz; C Baylis
Journal:  Hypertension       Date:  1998-12       Impact factor: 10.190

Review 7.  Vasodysfunction That Involves Renal Vasodysfunction, Not Abnormally Increased Renal Retention of Sodium, Accounts for the Initiation of Salt-Induced Hypertension.

Authors:  R Curtis Morris; Olga Schmidlin; Anthony Sebastian; Masae Tanaka; Theodore W Kurtz
Journal:  Circulation       Date:  2016-03-01       Impact factor: 29.690

8.  Influence of neonatal sympathectomy on proximal renal resistance artery function in spontaneously hypertensive rats.

Authors:  Olaf Grisk; Ulrike Lother; Gert Gabriëls; Rainer Rettig
Journal:  Pflugers Arch       Date:  2004-10-12       Impact factor: 3.657

Review 9.  Resuscitation-induced intestinal edema and related dysfunction: state of the science.

Authors:  Shinil K Shah; Karen S Uray; Randolph H Stewart; Glen A Laine; Charles S Cox
Journal:  J Surg Res       Date:  2009-09-29       Impact factor: 2.192

10.  Elevated renal perfusion pressure does not contribute to natriuresis induced by isotonic saline infusion in freely moving dogs.

Authors:  Erdmann Seeliger; Jens Lundbaek Andersen; Peter Bie; H Wolfgang Reinhardt
Journal:  J Physiol       Date:  2004-07-14       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.